tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Dyne Therapeutics Inc

DYN
Add to Watchlist
17.160USD
+0.150+0.88%
Close 11-13 16:00（ET）
3.20BMarket Cap
LossP/E TTM

Dyne Therapeutics Inc

17.160
+0.150+0.88%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

DYN Financials

See Dyne Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
3.20B
Dividend TTM
0.00
P/E TTM
-5.44
EPS TTM
-3.16
Revenue
--
Net Profit
-317.42M
ROE
-58.89%
ROA
-50.16%
Dyne Therapeutics Inc Earnings Date
Latest Release
Nov 5, 2026
EPS / Forecast
-1.06/-0.91
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-39.77%-1.06
-10.86%-1.08
30.23%-0.73
14.04%-0.75
20.87%-0.76
-38.33%-0.97
-29.57%-1.05
19.13%-0.88
2.28%-0.96
35.12%-0.70
-3.26%-0.81
-47.63%-1.09
---0.99
---1.08
---0.78
---0.73
----
----
----
----
Net Profit
-79.15%-193.55M
-61.07%-178.56M
-4.76%-120.85M
-25.03%-111.95M
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.10M
-48.57%-65.65M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.90M
-24.18%-44.19M
25.02%-38.83M
2.81%-41.38M
-74.61%-52.30M
-42.51%-35.58M
-80.76%-51.79M
Debt to assets ratio
59.64%18.26%
58.44%21.48%
--14.41%
--12.55%
--11.43%
--13.55%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Operating profit
-73.04%-197.07M
-56.89%-181.66M
-2.37%-125.28M
-19.59%-116.13M
-7.79%-113.89M
-60.91%-115.79M
-76.95%-122.37M
-43.46%-97.11M
-69.67%-105.66M
-7.83%-71.96M
-52.11%-69.16M
-68.61%-67.69M
-47.29%-62.27M
-26.50%-66.74M
-27.05%-45.46M
22.74%-40.15M
1.14%-42.28M
-74.89%-52.76M
-42.37%-35.78M
-81.68%-51.96M
Net Profit
-79.15%-193.55M
-61.07%-178.56M
-4.76%-120.85M
-25.03%-111.95M
-11.24%-108.04M
-70.28%-110.86M
-75.72%-115.36M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.10M
-48.57%-65.65M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.90M
-24.18%-44.19M
25.02%-38.83M
2.81%-41.38M
-74.61%-52.30M
-42.51%-35.58M
-80.76%-51.79M
Balance Sheet
Current assets
45.86%1.18B
34.38%937.89M
48.08%1.02B
70.88%1.13B
9.49%806.26M
-11.91%697.95M
41.25%689.50M
409.59%659.28M
337.76%736.39M
271.68%792.32M
95.87%488.14M
-51.29%129.38M
-34.86%168.22M
-28.45%213.17M
-27.65%249.21M
-30.54%265.59M
-39.19%258.23M
-35.41%297.93M
-29.28%344.45M
9.54%382.39M
Total current liabilities
51.29%90.55M
88.15%78.03M
51.26%51.25M
19.80%50.63M
38.35%59.85M
39.39%41.47M
51.51%33.88M
-17.30%42.26M
45.70%43.26M
47.14%29.75M
3.59%22.36M
81.91%51.09M
27.32%29.69M
-21.08%20.22M
-7.10%21.59M
-2.21%28.09M
-0.13%23.32M
76.08%25.62M
72.77%23.24M
161.90%28.72M
Total assets
42.41%1.23B
36.35%994.01M
49.77%1.08B
71.72%1.19B
12.77%867.06M
-11.73%728.99M
38.06%721.07M
318.72%691.23M
274.60%768.84M
228.49%825.88M
80.94%522.28M
-46.11%165.08M
-31.51%205.24M
-26.06%251.42M
-25.56%288.64M
-28.04%306.32M
-35.81%299.68M
-27.21%340.03M
-21.14%387.76M
20.47%425.66M
Total liabilities
73.37%303.87M
85.25%291.86M
312.46%214.90M
249.91%214.83M
176.88%175.28M
210.80%157.55M
17.81%52.10M
-16.80%61.40M
18.98%63.30M
13.80%50.69M
-5.32%44.22M
36.75%73.79M
6.55%53.21M
-15.90%44.54M
-8.96%46.71M
-6.10%53.96M
-5.36%49.94M
264.01%52.97M
281.43%51.30M
423.99%57.47M
Total equity
34.57%930.93M
22.87%702.15M
29.31%865.05M
54.35%972.13M
-1.95%691.78M
-26.28%571.45M
39.94%668.97M
589.92%629.84M
364.06%705.54M
274.71%775.19M
97.60%478.06M
-63.83%91.29M
-39.12%152.04M
-27.93%206.88M
-28.09%241.94M
-31.46%252.36M
-39.69%249.74M
-36.58%287.06M
-29.65%336.46M
7.54%368.20M
Cash Flow Statement
Net operating income
-95.52%-177.49M
-37.57%-130.29M
-36.86%-144.92M
-32.60%-111.83M
-21.64%-90.78M
-72.60%-94.70M
-34.83%-105.89M
-140.92%-84.33M
-47.48%-74.63M
1.39%-54.87M
-67.43%-78.54M
-19.92%-35.01M
-18.22%-50.60M
-80.02%-55.64M
7.55%-46.91M
-4.00%-29.19M
-58.82%-42.80M
33.02%-30.91M
-175.86%-50.74M
-40.09%-28.07M
Net investment
96.59%-1.29M
-170.79%-4.79M
-264.06%-2.39M
106.13%982.00K
-95.67%-37.97M
-39.38%6.77M
100.81%1.46M
-161.12%-16.01M
-251.34%-19.40M
-35.16%11.17M
-764.54%-179.84M
36.18%26.20M
-75.18%12.82M
-6.57%17.23M
1366.95%27.06M
8285.96%19.24M
1913.83%51.66M
386.65%18.44M
98.34%-2.14M
99.48%-235.00K
Net financing
92.38%418.10M
-42.34%58.11M
-95.00%7.06M
11752.72%430.96M
1106.77%217.33M
-73.47%100.77M
-65.41%141.24M
2373.47%3.64M
3866.74%18.01M
1425.18%379.86M
1317.28%408.39M
-99.60%147.00K
548.57%454.00K
25057.58%24.91M
159983.33%28.82M
41701.12%37.20M
-84.68%70.00K
296.00%99.00K
-99.99%18.00K
100.80%89.00K

FAQs

What are the current assets of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its current assets were 1.13B, with a year-on-year change of 70.88.

What are the total assets of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its total assets of Dyne Therapeutics Inc were 1.19B, with a year-on-year change of 71.72.

What are the total liabilities of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its total liabilities of Dyne Therapeutics Inc were 214.83M, with a year-on-year change of 249.91.

What is the total equity of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its total equity of Dyne Therapeutics Inc was 972.13M, with a year-on-year change of 54.35.

What is the net operating income of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its net operating income of Dyne Therapeutics Inc was -468.18M, with a year-on-year change of -36.15.

What is the net investment of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its net investment of Dyne Therapeutics Inc was -28.75M, with a year-on-year change of 85.91.

What is the net financing of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its net financing of Dyne Therapeutics Inc was 890.31M, with a year-on-year change of 9.93.

What is the Earnings Per Share (EPS) of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.47, with a year-on-year change of -3.04.

What is the net income of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its net income was -446.21M, with a year-on-year change of -40.58.

What is the Return on Equity (ROE) of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -55.71, with a year-on-year change of 36.72.

What is the Return on Assets (ROA) of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -47.52, with a year-on-year change of 35.91.

What is the operating profit of Dyne Therapeutics Inc?

According to Dyne Therapeutics Inc's FY2025 earnings report, its operating profit was -468.18M, with a year-on-year change of -36.15.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy